Tag: federal-judge
-
Regeneron CEO says Amgen not putting patients first in patent dispute
A federal judge last week handed Regeneron and its partner Sanofi a stunning setback by banning sales of their LDL-lowering medicine Praluent, finding it infringed patents held by Amgen on its Repatha cholesterol drug. Regeneron and Sanofi were given 30 days before the ban takes effect to give them time to appeal.
-
Planned Parenthood asks judge to halt Texas Medicaid cuts
AUSTIN, Texas (AP) — Planned Parenthood has asked a federal judge to stop Texas from cutting it from the state’s Medicaid program, which the nation’s largest abortion provider says would reduce health services for nearly 11,000 low-income women.
-
U.S. attorneys argue Aetna-Humana deal violates antitrust law
A U.S. Justice Department attorney told a federal judge on Monday that health insurer Aetna Inc's planned acquisition of Humana Inc would break antitrust law by reducing competition in Medicare Advantage and Obamacare exchange businesses, kicking off a trial expected to last weeks. The Justice Department filed a lawsuit in July asking the court to…
-
U.S. attorneys argue Aetna-Humana deal violates antitrust law
A U.S. Justice Department attorney told a federal judge on Monday that health insurer Aetna Inc's planned acquisition of Humana Inc would break antitrust law by reducing competition in Medicare Advantage and Obamacare exchange businesses, kicking off a trial expected to last weeks. The Justice Department filed a lawsuit in July asking the court to…
-
Many smartphone health apps don’t flag danger, says review
NEW YORK (AP) — Don’t count on smartphone health apps in an emergency: A review shows many don’t warn when you’re in danger.
-
Many smartphone health apps don’t flag danger, says review
NEW YORK (AP) — Don’t count on smartphone health apps in an emergency: A review shows many don’t warn when you’re in danger.
-
Patent for J&J’s Remicade invalidated, cheaper version looms
A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent …
-
Patent for J&J’s Remicade invalidated, cheaper version looms
A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent …
-
Britain seeks to fight the fat with soft drinks sugar levy
By Kate Kelland LONDON (Reuters) – Britain on Thursday launched a strategy aimed at curbing childhood obesity by taxing companies which sell sugar-laced soft drinks and investing that money in programmes to encourage physical activity and balanced diets for school children. Urging food and drinks firms to act swiftly to cut sugar in their products,…
-
Court: Birth control mandate violates religious rights
JEFFERSON CITY, Mo. (AP) — A federal judge has ruled in favor of a Missouri lawmaker who cited religious objections while challenging the inclusion of birth control coverage in his government-provided health insurance.